CHEONAN, SOUTH KOREA - DECEMBER 22: South Korean soldiers and national veterinary and quarantine service personnel on their way to bury hundreds of carcasses at a duck farm affected by a highly pathogenic avian influenza on December 22, 2003 in Cheonan, southeast of Seoul. Nearly a million chickens and ducks will be slaughtered across South Korea to combat a highly contagious strain of bird flu outbreak that has spread across the country and could also infect humans, the government said on Monday. (Photo by Chung Sung-Jun/Getty Images)
On May 28, the U.S. Department of Health and Human Services (HHS) canceled a $590 million contract to Moderna, a pharmaceutical and biotechnology company. The funding was awarded to the company in January and was intended to be used for developing a vaccine against H5 avian influenza (bird flu).
Bird flu originally targeted only avian animals, typically killing both wild birds and domesticated ones. However, it has spread to both land and sea mammals. While the flu doesn’t appear to be easily transmitted to people, scientists are concerned about the potential for a bird flu pandemic shortly due to the ability of viruses to mutate and change their properties.
Moderna had been awarded a contract worth $176 million in July 2024, under the Biden administration, due to an increase in bird flu infections among humans. In January, before the end of former President Joe Biden’s term in office, officials announced another contract, this time worth $590 million, to build upon the previous award and potentially find vaccines against pandemic flu diseases.
With President Donald Trump and his administration taking over, the DHS decided to cancel the contract.
Subscribe to our free weekly newsletter!
A week of political news in your in-box.
We find the news you need to know, so you don't have to.
HHS Secretary Robert F. Kennedy Jr. had consistently questioned the safety of mRNA technology, which Moderna implemented in its COVID-19 vaccine.
Health and Human Services spokesperson Andrew Nixon stated that the department had decided that investing in Moderna and its mRNA technology was not in the best interest of the department, considering the science and ethics behind the technology.
Moderna spokesperson Christopher Ridley had defended the technology, citing the results of the COVID-19 vaccine, which have given many people immunity against the disease.
mRNA technology, once introduced into the body via vaccines, instructs the body to produce a copy of part of the virus, allowing the immune system to respond and resist the disease when encountered.
Kennedy has suggested an alternative approach for containing the virus. He has proposed allowing the virus to infect a flock of birds, rather than identifying the bird responsible for the virus’s origin and then studying the immunity of birds that survive the virus. Many scientists have pointed out that this would be inhumane toward the birds and presents a danger to anyone within range of the virus, potentially leading to a pandemic.
https://www.youtube.com/shorts/DqVaz4a1Sjc After a monumental win in the New York City mayoral Democratic primary race, candidate…
A second whistleblower has come forward to accuse Emil Bove, the deputy attorney general who…
In 2020, Breonna Taylor was shot by a police officer during a raid on her…
President Donald Trump signed a new executive order that will expand involuntary treatment for people…
Infamous financier Jeffrey Epstein's newly surfaced 50th birthday book from 2003 reportedly contains messages from…
With many of the Fédération Internationale de Football Association (FIFA) Club World Cup tournaments scheduled…